In "Dengue Endemicity, Force of Infection and Variation in Transmission Intensity From 13 Endemic Countries" by Nealon et al \[*J Infect Dis* 2020; jiaa132\], the advance online publication contained three errors in [Table 3](#T3){ref-type="table"}, introduced through a Stata coding error. The legend for [Figure 2](#F2){ref-type="fig"} also incorrectly described the confidence intervals in the figure. The correct table and figures are provided below, and are correct in the printed version.

###### 

Ages at Which 50% and 80% of Children Become Dengue Seropositive, Per Country, Using Constant or Age-Varying Models

                Median Age at Seroconversion, y (95% CI)                         80th Percentile Age at Seroconversion, y (95% CI)   
  ------------- ------------------------------------------ --------------------- --------------------------------------------------- ----------------------
  India         **5.8 (5.5--6.1)**                         6.5 (6.0--6.9)        **13.5 (12.8--14.3)**                               11.1 (8.8--17.4)
  Indonesia     **4.7 (4.5--4.9)**                         4.6 (4.4--4.8)        **11.0 (10.5--11.5)**                               10.6 (10.1--11.2)
  Malaysia      **8.1 (7.1--9.2)**                         9.2 (5.9--\>18)       **18.8 (16.6--21.3)**                               \>18
  Philippines   2.9 (2.6--3.2)                             **1.6 (1.4--3.1)**    6.7 (6.1--7.4)                                      **8.7 (6.6--12.2)**
  Singapore     \>18                                       **\>18**              \>18                                                **\>18**
  Thailand      4.7 (4.2--5.2)                             **4.2 (3.7--4.9)**    10.9 (9.8--12.0)                                    **12.7 (0.0--40.2)**
  Vietnam       **6.1 (5.5--6.8)**                         5.1 (4.3--6.5)        **14.1 (12.7--15.7)**                               \>18
  Brazil        **6.5 (5.8--7.3)**                         7.5 (6.4--9.1)        **15.1 (13.4--17.0)**                               13.3 (11.9--17.4)
  Colombia      **3.8 (3.5--4.1)**                         3.7 (3.4--4.1)        **8.8 (8.1--9.5)**                                  8.6 (7.9--9.4)
  Honduras      **4.0 (3.5--4.5)**                         3.9 (3.3--4.7)        **9.2 (8.2--10.3)**                                 9.0 (7.7--10.9)
  Mexico        9.8 (8.8--10.9)                            **9.0 (8.0--10.4)**   \>18                                                **\>18**
  Peru          **7.5 (6.5--8.7)**                         10.6 (6.5--28.8)      **17.4 (15.1--20.2)**                               \>18
  Puerto Rico   8.2 (7.0--9.6)                             **7.9 (6.6--9.8)**    \>18                                                **\>18**

Best-fitting models are highlighted in bold.
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The authors regret the errors.
